ArticleThe Journal of thoracic and cardiovascular surgery2014

Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation.

Muhammad M Mohiuddin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.